William brings over 37 years of scientific leadership in the biotechnology and healthcare industry to Texas with 16 issued and licensed medical device patents and has been awarded over 9 million dollars in research funding. His academic training was in the areas of biomedical engineering/analytical chemistry and a graduate degree in Epidemiology from the London School of Hygiene and Tropical Medicine. William leads research development for Life Sciences Division of Tietronix, which specializes in advanced medical device software, and serves as Chief Scientific Officer for Tienovix. William is the Principal Investigator on medical research projects funded by the National Institutes of Health, The Defense Health Program, DoD and NASA to develop AI-empowered medical technologies for austere environments. Prior to these roles, William served scientific leadership roles at DuPont, Eli Lilly and Cyberonics, managed programs of scientific research consisting of as many as 200+ individual clinical/pre-clinical/engineering studies.